PROVIDENT FINANCIAL SERVICES INC Debt Disclosure
| 2025 | 2024 | ||||||||||
| Securities sold under repurchase agreements | $ | 95,007 | 113,224 | ||||||||
| FHLBNY line of credit | 275,000 | 385,000 | |||||||||
FHLBNY advances | 1,739,735 | 1,518,497 | |||||||||
| Purchase accounting adjustment on borrowed funds | 2,213 | 3,714 | |||||||||
| Total borrowed funds | $ | 2,111,955 | 2,020,435 | ||||||||
| 2025 | |||||
| Due in one year or less | $ | 1,464,735 | |||
| Due after one year through two years | 400,000 | ||||
| Due after two years through three years | — | ||||
| Due after three years through four years | 150,000 | ||||
| Due after four years through five years | — | ||||
| Thereafter | — | ||||
| Purchase accounting adjustment on borrowed funds | 2,213 | ||||
| Total FHLBNY advances, FRBNY BTFP borrowings and overnight borrowings | $ | 2,016,948 | |||
| 2025 | |||||
| Due in one year or less | $ | 95,007 | |||
| Thereafter | — | ||||
| Total securities sold under repurchase agreements | $ | 95,007 | |||
Maximum balance | Average balance | Weighted average interest rate | |||||||||||||||
| 2025 | |||||||||||||||||
| Securities sold under repurchase agreements | $ | 117,946 | 105,343 | 2.37 | % | ||||||||||||
| FHLBNY overnight borrowings | 704,000 | 292,090 | 4.55 | ||||||||||||||
| FHLBNY advances | 2,368,897 | 1,617,909 | 3.99 | ||||||||||||||
| 2024 | |||||||||||||||||
| Securities sold under repurchase agreements | $ | 117,323 | 102,043 | 2.03 | % | ||||||||||||
| FHLBNY overnight borrowings | 567,000 | 115,902 | 5.45 | ||||||||||||||
| FHLBNY advances | 1,518,497 | 1,290,836 | 3.41 | ||||||||||||||
| FRBNY BTFP Borrowing | 550,000 | 472,077 | 4.78 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Mar 1, 2023 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.